Tomoyasu Fukui

15PUBLICATIONS
48CO-AUTHORS
Traditional Chinese medicine and treatmentsMedical biochemistry - proteins and peptides (incl. medical proteomics)Epigenetics (incl. genome methylation and epigenomics)AutoimmunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 26, 2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura, Ichiro Horie, Hiroshi Yano

|Jun 13, 2025
Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J).

Shinsuke Noso, Daisuke Chujo, Akihisa Imagawa

|Jan 22, 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study.

Yuta Nakamura, Ichiro Horie, Tadahiro Kitamura

|Apr 28, 2023
Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus.

Tomoyasu Fukui, Tetsuro Kobayashi, Erika Jimbo

|Apr 21, 2023
Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.

Nobuaki Takehana, Tomoyasu Fukui, Yusaku Mori

|Jan 24, 2023
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes.

Eiji Kawasaki, Akira Shimada, Akihisa Imagawa

Pageof 3

Frequent Collaborators

5 joint publications

Tetsuro Kobayashi

4 joint publications

Michishige Terasaki

4 joint publications

Yusaku Mori

4 joint publications

Yoichi Oikawa